MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.800
-0.020 (-1.10%)
At close: Feb 9, 2026, 4:00 PM EST
1.790
-0.010 (-0.56%)
After-hours: Feb 9, 2026, 4:04 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $5.77 million as of February 9, 2026. Its market cap has decreased by -65.45% in one year.
Market Cap
5.77M
Enterprise Value
-8.37M
1-Year Change
-65.45%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $5.77M, a decrease of -99.99%. That is a compound annual growth rate of -79.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.84M | -68.50% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 6.31M |
| BiomX | 6.26M |
| Quoin Pharmaceuticals | 5.99M |
| Purple Biotech | 5.98M |
| VivoSim Labs | 5.95M |
| Alaunos Therapeutics | 5.87M |
| Mustang Bio | 5.75M |
| Can-Fite BioPharma | 5.56M |